EffPha completed a Pre-IND meeting

EffPha has assisted a Taiwanese big pharmaceutical company

EffPha has assisted a Taiwanese big pharmaceutical company to successfully obtain recommendation from the US FDA for the Phase I/IIa clinical study of their 505(b)2 small molecular new drug by helping them to prepare the questions, Pre-IND meeting package and submission in eCTD form.